본문 바로가기
KERD
논문KCI 등재

Cervical cancer in Thailand: 2023 update

Mayuree Wongpratate|Sureewan Bumrungthai
대한산부인과학회 (Korean Soceity of Obstetrics and Gynecology)|2024.05|Obstetrics & Gynecology Science|제67권 제3호|pp. 261-269|DOI 10.5468/ogs.23277

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

IncidenceMortalityVaccinationScreeningCervical cancer
주제분류산부인과학

초록

Cervical cancer continues to pose a challenge to the health of Thai women, as the second most common cancer after breast cancer. Since high-risk human papillomavirus (HPV) types are the main cause for cervical cancer, cervical cancer screening and HPV vaccination are necessary to reduce the incidence of this disease. At present, the World Health Organization hopes to reduce the incidence of cervical cancer to 4 or less cases per 100,000 women-years using 90%- 70%-90% intervention by 2030. The first intervention involves vaccinating 90% of women aged 15 years with the HPV vaccine. The second intervention involves screening 70% of women between the ages of 35 and 45 years using a high-performance screening test. The third intervention involves detecting cervical lesions in 90% of affected women to enable diagnosis and treatment. In this context, this study reviews trends in the incidence and mortality rates of cervical cancer in Thailand, in addition to providing an up-to-date overview of the causes and necessary risk factors for cervical cancer, as well as reporting on cervical screening and HPV vaccination rates and cervical cancer during the coronavirus disease 2019 (COVID-19) pandemic. This study may prove useful for the formulation of policy aimed at eliminating cervical cancer in Thailand, such as the implementation of a free HPV vaccine service and providing athome kits for cervical screening through clinics and pharmacies. In addition, this review also highlights the need for further research on the effects of the COVID-19 pandemic on cervical cancer screening rates in Thailand.

Abstract

Cervical cancer continues to pose a challenge to the health of Thai women, as the second most common cancer after breast cancer. Since high-risk human papillomavirus (HPV) types are the main cause for cervical cancer, cervical cancer screening and HPV vaccination are necessary to reduce the incidence of this disease. At present, the World Health Organization hopes to reduce the incidence of cervical cancer to 4 or less cases per 100,000 women-years using 90%- 70%-90% intervention by 2030. The first intervention involves vaccinating 90% of women aged 15 years with the HPV vaccine. The second intervention involves screening 70% of women between the ages of 35 and 45 years using a high-performance screening test. The third intervention involves detecting cervical lesions in 90% of affected women to enable diagnosis and treatment. In this context, this study reviews trends in the incidence and mortality rates of cervical cancer in Thailand, in addition to providing an up-to-date overview of the causes and necessary risk factors for cervical cancer, as well as reporting on cervical screening and HPV vaccination rates and cervical cancer during the coronavirus disease 2019 (COVID-19) pandemic. This study may prove useful for the formulation of policy aimed at eliminating cervical cancer in Thailand, such as the implementation of a free HPV vaccine service and providing athome kits for cervical screening through clinics and pharmacies. In addition, this review also highlights the need for further research on the effects of the COVID-19 pandemic on cervical cancer screening rates in Thailand.

참고문헌 (70)

  1. Bhatla N, "Cancer of the cervix uteri: 2021 update", Int J Gynaecol Obstet, 155(Suppl 1), pp.28~44 (2021)
  2. Singh D, "Global estimates of incidence and mortality of cervical cancer in 2020 : a baseline analysis of the WHO global cervical cancer elimination initiative", Lancet Glob Health, 11, pp.e197~e206 (2023)
  3. "Hospital-based cancer registry 2021" (2022)[URL]
  4. "Cancer in Thailand Vol. V, 2001-2003" (2010)[URL]
  5. "Cancer in Thailand Vol. VI, 2004-2006" (2012)[URL]
  6. "Cancer in Thailand Vol. VII, 2007-2009" (2013)[URL]
  7. "Cancer in Thailand Vol. VIII, 2010-2012" (2015)[URL]
  8. "Cancer in Thailand Vol. IX, 2013-2015" (2018)[URL]
  9. "Cancer in Thailand Vol. X, 2016-2018" (2021)[URL]
  10. "Public health statistics A.D. 2012" (2013)[URL]
  11. Ministry of Public Health, "Public health statistics A.D. 2015" (2015), Ministry of Public Health
  12. "Public health statistics A.D. 2019" (2020)[URL]
  13. "Public health statistics A.D. 2020" (2021)[URL]
  14. "Public health statistics A.D. 2021" (2022)[URL]
  15. Chichareon S, "Risk factors for cervical cancer in Thailand : a case-control study", J Natl Cancer Inst, 90, pp.50~57 (1998)
  16. Settheetham-Ishida W, "Human papillomavirus genotypes and the p53codon 72 polymorphism in cervical cancer of Northeastern Thailand", Microbiol Immunol, 49, pp.417~421 (2005)
  17. Natphopsuk S, "Risk factors for cervical cancer in northeastern Thailand : detailed analyses of sexual and smoking behavior", Asian Pac J Cancer Prev, 13, pp.5489~5495 (2012)
  18. World Health Organization, "Comprehensive cervical cancer control: a guide to essential practice" (2014), World Health Organization
  19. "Thailand: human papillomavirus and related cancers, fact sheet 2023" (2023)[URL]
  20. Frazer I, "Correlating immunity with protection for HPV infection", Int J Infect Dis, 11(Suppl 2), pp.S10~S16 (2007)
  21. Stanley M, "HPV-immune response to infection and vaccination", Infect Agent Cancer, 5, pp.19~ (2010)
  22. Stanley M, "Pathology and epidemiology of HPV infection in females", Gynecol Oncol, 117, pp.S5~S10 (2010)
  23. Panatto D, "Sexual behaviour and risk factors for the acquisition of human papillomavirus infections in young people in Italy : suggestions for future vaccination policies", BMC Public Health, 12, pp.623~ (2012)
  24. Bouvard V, "The IARC perspective on cervical cancer screening", N Engl J Med, 385, pp.1908~1918 (2021)
  25. Song D, "Effect of human papillomavirus infection on the immune system and its role in the course of cervical cancer", Oncol Lett, 10, pp.600~606 (2015)
  26. Gupta SM, "Molecular mechanisms in progression of HPV-associated cervical carcinogenesis", J Biomed Sci, 26, pp.28~ (2019)
  27. Regauer S, "The origin of human papillomavirus(HPV)-induced cervical squamous cancer", Curr Opin Virol, 51, pp.111~118 (2021)
  28. Alzamil L, "Organoid systems to study the human female reproductive tract and pregnancy", Cell Death Differ, 28, pp.35~51 (2021)
  29. Deng H, "HPV16-immortalized cells from human transformation zone and endocervix are more dysplastic than ectocervical cells in organotypic culture", Sci Rep, 8, pp.15402~ (2018)
  30. Doorbar J, "Refining our understanding of cervical neoplasia and its cellular origins", Papillomavirus Res, 7, pp.176~179 (2019)
  31. Sriamporn S, "Behavioural risk factors for cervical cancer from a prospective study in Khon Kaen, Northeast Thailand", Cancer Detect Prev, 28, pp.334~339 (2004)
  32. Ishida WS, "Co-risk factors for HPV infection in Northeastern Thai women with cervical carcinoma", Asian Pac J Cancer Prev, 5, pp.383~386 (2004)
  33. Phuthong S, "Genetic polymorphisms of vitamin D receptor gene are associated with cervical cancer risk in Northeastern Thailand", Asian Pac J Cancer Prev, 21, pp.2935~2939 (2020)
  34. Li D, "Vitamin D receptor gene polymorphisms and the risk of CIN2+ in Shanxi population", Biomed Res Int, 2022, pp.6875996~ (2022)
  35. Wongpratate M, "Genetic polymorphisms of the human cytochrome P450 1A1(CYP1A1)and cervical cancer susceptibility among Northeast Thai women", Asian Pac J Cancer Prev, 21, pp.243~248 (2020)
  36. Wu B, "MspI and Ile462Val polymorphisms in CYP1A1and overall cancer risk : a meta-analysis", PLoS One, 8, pp.e85166~ (2013)
  37. Ding B, "Cytochrome P450 1A1 gene polymorphisms and cervical cancer risk: a systematic review and meta-analysis", Medicine(Baltimore), 97, pp.e0210~ (2018)
  38. Settheetham-Ishida W, "Genetic polymorphism of glutathione S-transferase and cervical cancer susceptibility in Northeastern Thailand", APJCB, 5, pp.35~41 (2020)
  39. Ye J, "Individual effects of GSTM1 and GSTT1 polymorphisms on cervical or ovarian cancer risk : an updated meta-analysis", Front Genet, 13, pp.1074570~ (2023)
  40. Sobti RC, "Interaction of passive smoking with GST(GSTM1, GSTT1, and GSTP1)genotypes in the risk of cervical cancer in India", Cancer Genet Cytogenet, 166, pp.117~123 (2006)
  41. Phuthong S, "Haplotype analysis of MDR1and risk for cervical cancer in Northeastern Thailand", Asian Pac J Cancer Prev, 18, pp.1815~1819 (2017)
  42. Ploysawang P, "National cervical cancer screening in Thailand", Asian Pac J Cancer Prev, 22, pp.25~30 (2021)
  43. Gottschlich A, "Barriers to cervical cancer screening and acceptability of HPV self-testing : a crosssectional comparison between ethnic groups in Southern Thailand", BMJ Open, 9, pp.e031957~ (2019)
  44. Termrungruanglert W, "The epidemiologic and economic impact of a quadrivalent human papillomavirus vaccine in Thailand", PLoS One, 16, pp.e0245894~ (2021)
  45. Juntasopeepun P, "Human papillomavirus vaccination intention among young women in Thailand", Asian Pac J Cancer Prev, 12, pp.3213~3219 (2011)
  46. Ratanasiripong NT, "Human papillomavirus(HPV)vaccination and factors related to intention to obtain the vaccine among young college women in Thailand", J Health Res, 32, pp.142~151 (2018)
  47. Chanprasertpinyo W, "Human papillomavirus(HPV)vaccine status and knowledge of students at a university in rural Thailand", Heliyon, 6, pp.e04625~ (2020)
  48. Klinsupa W, "O16. 3 Hpv vaccine introduction in thailand", Sex Transm Infect, 91, pp.A1~A258 (2015)
  49. Ong SK, "Towards elimination of cervical cancer-human papillomavirus(HPV)vaccination and cervical cancer screening in Asian National Cancer Centers Alliance(ANCCA)member countries", Lancet Reg Health West Pac, 39, pp.100860~ (2023)
  50. Santhanes D, "Factors influencing intention to obtain the HPV vaccine in South East Asian and Western Pacific regions : a systematic review and meta-analysis", Sci Rep, 8, pp.3640~ (2018)
  51. Kruiroongroj S, "Knowledge, acceptance, and willingness to pay for human papilloma virus(HPV)vaccination among female parents in Thailand", Asian Pac J Cancer Prev, 15, pp.5469~5474 (2014)
  52. Klaipuk P, "Improved knowledge about HPV in Thai women after educational intervention", JDAT-DFCT, 69, pp.1~7 (2019)
  53. Chunuan S, "A predictive model of human papillomavirus vaccination intention among young women in Southern Thailand", Pac Rim Int J Nurs Res, 25, pp.298~311 (2021)
  54. "Coronavirus disease (COVID‐19)" (2023)[URL]
  55. Duarte MBO, "Impact of COVID-19 in cervical and breast cancer screening and systemic treatment in São Paulo, Brazil : an interrupted time series analysis", JCO Glob Oncol, 8, pp.e2100371~ (2022)
  56. Castanon A, "COVID-19 disruption to cervical cancer screening in England", J Med Screen, 29, pp.203~208 (2022)
  57. Fedewa SA, "Changes in cancer screening in the US during the COVID-19 pandemic", JAMA Netw Open, 5, pp.e2215490~ (2022)
  58. Lucas E, "Quantification of impact of COVID-19 pandemic on cancer screening programmes-a case study from Argentina, Bangladesh, Colombia, Morocco, Sri Lanka, and Thailand", Elife, 12, pp.e86527~ (2023)
  59. Eamratsameekool W, "Comparison of self-to provider-collected cervical screening with HPV DNA test at roi Et province, Thailand during COVID-19 pandemic", J Med Assoc Thai, 106, pp.8~13 (2023)
  60. "Regional implementation framework for elimination of cervical cancer as a public health problem: 2021-2030" (2021)[URL]
  61. Sripan P, "Impact of universal health care and screening on incidence and survival of Thai women with cervical cancer : a population-based study of the Chiang Mai province", Cancer Epidemiol, 63, pp.101594~ (2019)
  62. Ngamphaiboon N, "PSY7-5 current status of HPV vaccination and HPV-associated head and neck cancer in Thailand", Ann Oncol, 33, pp.S422~ (2022)
  63. "Policy driving plan, Ministry of Public Health" (2023)[URL]
  64. Wannasin R, "Survival after diagnosis of cervical cancer patients at a tertiary referral hospital in Northeast Thailand", Asian Pac J Cancer Prev, 24, pp.1759~1767 (2023)
  65. Bangsomboon P, "Survival rate of cervical cancer patients according to the 2018 FIGO staging system : a tertiary hospital based study, Vajira Hospital, Bangkok", Thai J Obstet Gynaecol, 30, pp.60~67 (2022)
  66. Yun BS, "Incidence and survival of gynecologic cancer including cervical, uterine, ovarian, vaginal, vulvar cancer and gestational trophoblastic neoplasia in Korea, 1999-2019 : Korea Central Cancer Registry", Obstet Gynecol Sci, 66, pp.545~561 (2023)
  67. Landy R, "Impact of screening on cervical cancer incidence : a population-based case-control study in the United States", Int J Cancer, 147, pp.887~896 (2020)
  68. Ha HI, "The incidence and survival of cervical, ovarian, and endometrial cancer in Korea, 1999-2017 : Korea central cancer registry", Obstet Gynecol Sci, 64, pp.444~453 (2021)
  69. eClinicalMedicine, "Global strategy to eliminate cervical cancer as a public health problem : are we on track?", eClinicalMedicine, 55, pp.101842~ (2023)
  70. Burmeister CA, "Cervical cancer therapies : current challenges and future perspectives", Tumour Virus Res, 13, pp.200238~ (2022)

관련 논문AI추천

Attitude toward human papillomavirus self-sampling and associated factors among Thai women undergoing colposcopyAwassada Punyashthira, Komsun Suwannarurk, Nida Jareemit, Nopwaree Chantawong, Perapong Inthasorn, Pichamon Sukkasame, Piyawan Pariyawateekul, Siriwan Tangjitgamol, Thai Gynecologic Cancer Society Research Group대한산부인과학회 · Obstetrics & Gynecology Science2024 · 제67권 제3호Human papillomavirus genotype distribution in lowgrade squamous intraepithelial lesion cytology, and its immediate risk for high-grade cervical lesion or cancer: a single-center, cross-sectional studyBoonlert Viriyapak, Irene Ruengkhachorn, Mongkol Benjapibal, Navin Horthongkham, Nida Jareemit, Perapong Inthasorn, Suwanit Therasakvichya, Vuthinun Achariyapota대한산부인과학회 · Obstetrics & Gynecology Science2022 · 제65권 제4호Incidence and mortality of cervical cancer in Vietnam and Korea (1999-2017)기모란, 오진경, Byung-Woo Kim, Kim Ngoc Tran, Yoon Park한국역학회 · Epidemiology and Health2020 · 제42권 Proposal for cervical cancer screening in the era of HPV vaccination오영택, 이재관대한산부인과학회 · Obstetrics & Gynecology Science2018 · 제61권 제3호Decoding impact of human papillomavirus in gynecological oncology: a narrative reviewMd. Safiullah Sarker, Mohammed Moshtaq Pervez대한산부인과학회 · Obstetrics & Gynecology Science2025 · 제68권 제1호자궁경부암 진단에 HPV DNA검사의 역할이재관대한산부인과학회 · Obstetrics & Gynecology Science2006 · 제49권 제2호

이 간행물의 다른 논문 (10건)

The timing of adenomyosis diagnosis and its impact on pregnancy outcomes: a national population-based studyHwa Seon Koo, Wonyoung Wi, Young Mi Jung, Soo-Young Oh, Jin Hoon Chung, Min-Jeong Oh, Geum Joon Cho, Seung-Hyuk Shim, Hyunjin Cho, 조시현, Seung Mi Lee, Hye-Sung Wonpp. 270-278A randomized controlled study comparing oral misoprostol with intramuscular oxytocin in active management of third stage of labourMunir’deen Aderemi Ijaiya, Atanda Abdulrasaq Sambo, Duum Nwachukwu, Ikemefuna Christopher Nwosu, Haruna Idris, Rasheedat Morayo Abdullateef, Folorunsho Benard Adewalepp. 279-285Attitude toward human papillomavirus self-sampling and associated factors among Thai women undergoing colposcopyThai Gynecologic Cancer Society Research Group, Siriwan Tangjitgamol, Nida Jareemit, Perapong Inthasorn, Pichamon Sukkasame, Awassada Punyashthira, Nopwaree Chantawong, Komsun Suwannarurk, Piyawan Pariyawateekulpp. 286-295Determination of ovarian transposition through prediction of postoperative adjuvant therapy in young patients with early stage cervical cancer undergoing surgery: a Korean multicenter retrospective study (KGOG 1042)Yun Hwan Kim, Myounghwan Kim, Banghyun Lee, Myong Cheol Lim, Woo Yeon Hwang, Seok Ju Seong, Kidong Kim, Moon-Hong Kim, Chel Hun Choi, Jong-Min Leepp. 296-303Clinical effectiveness of spindle-view intracytoplasmic sperm injection compared to conventional intracytoplasmic sperm injection in patients with poor ovarian response and previous implantation failureJae Hong Joo, Sungwook Chun, Yun Hee Koo, Tae Woo Park, Yong Chan Lee, Suji Kim, Minkyung Chopp. 304-313
원문 보기